نتایج جستجو برای: dlbcl lymphoma

تعداد نتایج: 102737  

2012
Kenneth A. Foon Kenichi Takeshita Pier L. Zinzani

Aggressive B-cell lymphoma (BCL) comprises a heterogeneous group of malignancies, including diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma, and mantle cell lymphoma (MCL). DLBCL, with its 3 subtypes, is the most common type of lymphoma. Advances in chemoimmunotherapy have substantially improved disease control. However, depending on the subtype, patients with DLBCL still exhibit substa...

2015
Anila Kanna Swati Agrawal Kumar Jayant Varun Kumar Pala Mohammad Altujjar Tarik Hadid Muhammad Khurram

B cell lymphoma, unclassifiable, with features of diffuse large B cell lymphoma and classical Hodgkin's lymphoma (BCLu-DLBCL/CHL) is more commonly known as gray zone lymphoma. These cases more often present with mediastinal disease. In this report, we present a very rare case of BCLu-DLBCL/CHL without mediastinal involvement, transformed from follicular lymphoma (FL) to BCLu-DLBCL/CHL. This pat...

2009
Robert P. Hasserjian German Ott Kojo S. J. Elenitoba-Johnson Olga Balague-Ponz Daphne de Jong Laurence de Leval

The 2008 WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues has introduced two new categories of high-grade B-cell lymphomas: entities in which features of diffuse large B-cell lymphoma (DLBCL) overlap with Burkitt lymphoma (DLBCL/BL) or classical Hodgkin lymphoma (DLBCL/HL). The DLBCL/BL category encompasses cases that resemble Burkitt lymphoma morphologically, but have one or...

2014
TOMOKO YAMASHITA MITSUAKI ISHIDA HIROKO MORO HIROFUMI YUMOTO SACHIKO UCHIBAYASHI MIYUKI YOSHII RYOTA NAKANISHI HIROKO OKUNO TAKASHI YOSHIDA TAKAFUMI OKUNO KEIKO HODOHARA HIDETOSHI OKABE

Cold agglutinin disease (CAD) is a well-recognized complication of lymphoproliferative disorders. It has been previously recognized that cases of primary CAD frequently exhibit underlying malignant lymphoma in the bone marrow. Lymphoplasmacytic lymphoma is the most common subtype of malignant lymphoma; however, diffuse large B-cell lymphoma (DLBCL) has also been documented, albeit extremely rar...

2011
Mark S. Friedman Ishwaria M. Subbiah Geeta Arora Gregg Brodsky Vinay Sood

Diffuse large B cell lymphoma (DLBCL) is the most common histologic subtype of Non-Hodgkin’s lymphoma (NHL), accounting for approximately twenty five percent of cases. Forty percent of patients with DLBCL present with the primary lesion in an extranodal site. The gastrointestinal tract is the most frequent site of extranodal lymphoma, with the stomach and intestines most often involved. Involve...

2017
Akashi Fujita Masahiro Tajika Tsutomu Tanaka Makoto Ishihara Yutaka Hirayama Nobumasa Mizuno Kazuo Hara Susumu Hijioka Hiroshi Imaoka Tsukasa Yoshida Nozomi Okuno Nobuhiro Hieda Takashi Hirayama Hitoshi Shibuya Hisashi Kondo Hirotaka Suzuki Kazuhiro Toriyama Yasushi Yatabe Kenji Yamao Yasumasa Niwa

API2-MALT1 translocation-positive gastric marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT) lymphoma is thought to transform to diffuse large B-cell lymphoma (DLBCL) rarely. A 69-year-old man presented with epigastralgia. Esophagogastroduodenoscopy showed multiple ulcerations in the stomach. Endoscopic biopsies revealed MALT lymphoma, with Helicobacter pylori infection. The pa...

2008
Yaso Natkunam

Introduction Diffuse large B-cell lymphoma (DLBCL), the most common adult non-Hodgkin lymphoma, is well recognized as a heterogeneous disease. Although clinical indicators such as the International Prognostic Index (IPI) are used to define prognostic subgroups of DLBCL, less than half of the patients with this disease are cured by currently available therapy. At present, a consensus approach fo...

Journal: :Blood 2014
Carmen Muñiz Lourdes Martín-Martín Antonio López Blanca Sánchez-González Antonio Salar Julia Almeida Juan-Manuel Sancho José María Ribera Cecilia Heras Francisco Javier Peñalver Marta Gómez Eva González-Barca Natalia Alonso Belén Navarro Teresa Olave Francisco Sala Eulogio Conde José Antonio Márquez Elena Cabezudo Antonia Cladera María García-Malo María Dolores Caballero Alberto Orfao

Flow cytometry (FCM) is more sensitive than conventional cytology for detection of occult leptomeningeal lymphoma; however, some FCM-negative patients show central nervous system (CNS) recurrence. Here, we evaluated the cerebrospinal fluid (CSF) levels of 13 B-cell-associated markers and their contribution to the diagnosis of CNS lymphoma in 91 diffuse large B-cell lymphomas (DLBCL) and 22 Burk...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2001
B Maes A Anastasopoulou J C Kluin-Nelemans I Teodorovic R Achten A Carbone C De Wolf-Peeters

BACKGROUND The EORTC clinical trial 20901, activated in 1990, was designed to treat non-Hodgkin's lymphomas (NHL) of intermediate/high-grade malignancy according to the Working Formulation. Established in 1994, the R.E.A.L. Classification on NHL has now replaced all former classifications. PATIENTS AND METHODS We reanalysed all cases (n = 273) documented by material available for review accor...

Journal: :Science 2008
Georg Lenz R Eric Davis Vu N Ngo Lloyd Lam Thaddeus C George George W Wright Sandeep S Dave Hong Zhao Weihong Xu Andreas Rosenwald German Ott Hans Konrad Muller-Hermelink Randy D Gascoyne Joseph M Connors Lisa M Rimsza Elias Campo Elaine S Jaffe Jan Delabie Erlend B Smeland Richard I Fisher Wing C Chan Louis M Staudt

Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin's lymphoma. In the least curable (ABC) subtype of DLBCL, survival of the malignant cells is dependent on constitutive activation of the nuclear factor-kappaB (NF-kappaB) signaling pathway. In normal B cells, antigen receptor-induced NF-kappaB activation requires CARD11, a cytoplasmic scaffolding protein. To determine w...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید